These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9293041)

  • 81. MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
    Schifano F; Di Furia L; Forza G; Minicuci N; Bricolo R
    Drug Alcohol Depend; 1998 Sep; 52(1):85-90. PubMed ID: 9788011
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ecstasy (MDMA): a review of its possible persistent psychological effects.
    Morgan MJ
    Psychopharmacology (Berl); 2000 Oct; 152(3):230-48. PubMed ID: 11105933
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.
    Vollenweider FX; Gamma A; Liechti M; Huber T
    Neuropsychopharmacology; 1998 Oct; 19(4):241-51. PubMed ID: 9718588
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impaired executive function in male MDMA ("ecstasy") users.
    von Geusau NA; Stalenhoef P; Huizinga M; Snel J; Ridderinkhof KR
    Psychopharmacology (Berl); 2004 Sep; 175(3):331-41. PubMed ID: 15034712
    [TBL] [Abstract][Full Text] [Related]  

  • 85. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.
    Hernández-López C; Farré M; Roset PN; Menoyo E; Pizarro N; Ortuño J; Torrens M; Camí J; de La Torre R
    J Pharmacol Exp Ther; 2002 Jan; 300(1):236-44. PubMed ID: 11752122
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans.
    Liechti ME; Vollenweider FX
    Eur Neuropsychopharmacol; 2000 Jul; 10(4):289-95. PubMed ID: 10871712
    [TBL] [Abstract][Full Text] [Related]  

  • 87. How MDMA's pharmacology and pharmacokinetics drive desired effects and harms.
    Michael White C
    J Clin Pharmacol; 2014 Mar; 54(3):245-52. PubMed ID: 24431106
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).
    Ho E; Karimi-Tabesh L; Koren G
    Neurotoxicol Teratol; 2001; 23(6):561-7. PubMed ID: 11792525
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Greater empathy in MDMA users.
    Carlyle M; Stevens T; Fawaz L; Marsh B; Kosmider S; Morgan CJ
    J Psychopharmacol; 2019 Mar; 33(3):295-304. PubMed ID: 30717615
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study.
    Huizink AC; Ferdinand RF; van der Ende J; Verhulst FC
    BMJ; 2006 Apr; 332(7545):825-8. PubMed ID: 16500927
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gender differences in the subjective effects of MDMA.
    Liechti ME; Gamma A; Vollenweider FX
    Psychopharmacology (Berl); 2001 Mar; 154(2):161-8. PubMed ID: 11314678
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.
    Cami J; Farré M; Mas M; Roset PN; Poudevida S; Mas A; San L; de la Torre R
    J Clin Psychopharmacol; 2000 Aug; 20(4):455-66. PubMed ID: 10917407
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
    Prada C; Alvarez FJ
    Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216
    [No Abstract]   [Full Text] [Related]  

  • 94. Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Szigeti B; Winstock AR; Erritzoe D; Maier LJ
    J Psychopharmacol; 2018 Jul; 32(7):741-748. PubMed ID: 29733742
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Working memory deficits in current and previous users of MDMA ('ecstasy').
    Wareing M; Fisk JE; Murphy PN
    Br J Psychol; 2000 May; 91 ( Pt 2)():181-8. PubMed ID: 10832513
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.
    Bedi G; Hyman D; de Wit H
    Biol Psychiatry; 2010 Dec; 68(12):1134-40. PubMed ID: 20947066
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA.
    Sessa B; Aday JS; O'Brien S; Curran HV; Measham F; Higbed L; Nutt DJ
    J Psychopharmacol; 2022 Mar; 36(3):360-367. PubMed ID: 34894842
    [TBL] [Abstract][Full Text] [Related]  

  • 98. (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.
    Morley KC; McGregor IS
    Eur J Pharmacol; 2000 Nov; 408(1):41-9. PubMed ID: 11070182
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake.
    Yubero-Lahoz S; Kuypers KP; Ramaekers JG; Langohr K; Farré M; de la Torre R
    Psychopharmacology (Berl); 2015 Jun; 232(11):1921-9. PubMed ID: 25524139
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Relationship between ecstasy use and depression: a study controlling for poly-drug use.
    Roiser JP; Sahakian BJ
    Psychopharmacology (Berl); 2004 May; 173(3-4):411-7. PubMed ID: 14652710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.